High-risk patients with negative findings at low-dose CT lung cancer screening are still at a high risk of developing lung cancer later in life, according to a new study published in Radiology. The authors tracked 200 patients who had negative findings at screening more than three years ago, and detected lung cancer in 7% of participants. The study shows that, in order to be effective, screenings should continue consistently beyond three years.
The full article is available here.
In order for patients to receive the proper follow up for their screenings, healthcare facilities need the right platform in place to track patients and ensure they have been followed up on appropriately. The Quantitative Imaging Decision Support (QIDS)™ platform provides functionality to manage lung cancer screening (LCS) programs and track patients over time so no one falls through the cracks.